Eosinophil Count

How it works

Dosage & preparation

Comparisons

Evidence quality

Other

Other

Highlighted claims

• The baseline median eosinophil count for the benralizumab group was corrected from 1,070.0 to 1,085.0 cells, with the lower range boundary raised from 230 to 360. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The baseline median eosinophil count in the benralizumab group was corrected from 1,070.0 to 1,085.0 cells, and the lower range boundary was raised from 230 to 360 cells. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The corrected baseline median eosinophil count for the total trial population was 1,100.0 cells with a range of 60–20,910. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The total population baseline median eosinophil count was corrected downward from 1,120.0 to 1,100.0 cells, with the observed range (60–20,910) remaining unchanged. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The baseline median eosinophil count in the benralizumab group was corrected from 1,070.0 to 1,085.0 cells, with the lower range bound raised from 230 to 360 cells. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The baseline median eosinophil count in the benralizumab group was corrected from 1,070.0 to 1,085.0 cells, with the lower range boundary raised from 230 to 360. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The corrected total population baseline median eosinophil count is 1,100.0 cells, decreased by 20 cells from the originally reported 1,120.0. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The corrected baseline median eosinophil count for the benralizumab group (n=67) is 1,085.0 cells with a range of 360–5,620. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• The corrected baseline median eosinophil count for the entire trial population is 1,100.0 cells with a range of 60–20,910. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
• Baseline eosinophil counts directly influence interpretation of treatment efficacy in hypereosinophilic syndrome trials. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems